Erector Spinae Plane Block for Postoperative Analgesia for Laparoscopic Cholecystectomy

The Effect of Erector Spinae Plane Block on Postoperative Pain Following Laparoscopic Cholecystectomy: A Randomized Controlled Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03420703

Enrollment

Registered

2018-02-05

Start date

2018-02-24

Completion date

2018-04-18

Last updated

2018-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

erector spinae plane block, laparoscopic cholecystectomy, postoperative pain

Brief summary

Erector Spinae Plane Block is a newly defined regional anesthesia technique. Its use for many indications has been identified by case reports in the literature. As the investigators have considered that erector spinae plane block could be efficacious for providing postoperative analgesia in laparoscopic cholecystectomy, the investigators have implemented application of this blockade into practice at the clinic. Main purpose of this study is to evaluate the analgesic effect of ultrasound guided erector spinae block in laparoscopic cholecystectomy.

Interventions

OTHERerector spinae plane block

ultrasound guided erector spinae plane block will be administered to this group.

DEVICEIntravenous morphine patient controlled analgesia device

Intravenous morphine patient controlled analgesia device will be given to the patients postoperatively and 24 hour morphine consumption will be recorded

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to 75 Years

Healthy volunteers

Inclusion criteria

* 25 - 75 years of age * ASA I - II * Undergoing elective laparoscopic cholecystectomy

Exclusion criteria

* obesity * ASA III - IV * infection of the skin at the site of needle puncture area * patients with known allergies to any of the study drugs * coagulopathy * recent use of analgesic drugs

Design outcomes

Primary

Measure	Time frame	Description
24h morphine consumption	for postoperative 24 hour	morphine consumptions for both group will be recorded

Secondary

Measure	Time frame	Description
Postoperative nausea and vomiting	24 hour	PONV after surgery was questioned
Pain	24h	Numeric rating scales were recorded

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026